Your session is about to expire
← Back to Search
Telehealth for AML and MDS
N/A
Waitlist Available
Led By Kah Poh Loh
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial tests if a telehealth service can provide better end-of-life planning for older adults with AML or MDS and their families.
Who is the study for?
This trial is for older patients, aged 60 and above, with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). They should be receiving outpatient care, able to give informed consent, speak English, and have a close contact involved in their health matters.Check my eligibility
What is being tested?
The study is testing the use of telehealth to deliver advance care planning guidance to these patients. It aims to assess how easy it is for participants and their healthcare providers to use this technology effectively.See study design
What are the potential side effects?
Since this trial involves telehealth services rather than medications or medical procedures, traditional physical side effects are not expected. However, participants may experience emotional or psychological impacts from discussing advanced care plans.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility - Retention rate
Recruitment rate
Usability
Secondary outcome measures
Post-intervention only
Pre-post changes
Trial Design
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
The SICG program consists of the Serious Illness Conversation Guide as well as training and system-level support for physicians to conduct ACP conversations.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telehealth
2013
N/A
~42390
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
836 Previous Clinical Trials
518,148 Total Patients Enrolled
Kah Poh LohPrincipal InvestigatorUniv. of Rochester Wilmot Cancer Center
5 Previous Clinical Trials
290 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Experimental
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any participants being sought out at the moment for this research study?
"Affirmative. Clinicaltrials.gov states that this clinical trial, originally advertised on March 25th 2021, is currently seeking applicants. Approximately 20 individuals are needed to be recruited from 2 medical locations."
Answered by AI
How many participants is the medical trial enrolling at this time?
"Affirmative. According to clinicaltrials.gov, this research project is accepting patients at the time of writing. The trial was first announced on March 25th 2021 and has been updated as recently as January 9th 2023. This investigation requires a total of 20 participants across 2 medical sites for completion."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger